Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms - Bernsdorf, A; Giessmann, T; Modess, C (Br J Clin Pharmacol, 2006)
et al.